Virus News and Research

Latest Virus News and Research

FDA to review bone drugs; CDC reports parasite may be a risk to blood supply

Two advisory panels of the Food and Drug Administration will consider on Friday whether to recommend requiring women who use popular bone drugs like Fosamax to take "drug holidays" because of rising concerns about rare side effects with long-term use, according to people involved in the review.

7 Sep 2011

'No evidence' mutant bird flu virus poses increased risk to humans, WHO and FAO say

After the U.N. Food and Agriculture Organization (FAO) "last week voiced concern about the appearance in Vietnam and China of" a mutant strain of the H5N1 bird flu virus, the WHO and FAO on Monday "said in a joint statement issued in response to questions from Agence France-Presse" that "there is no evidence to suggest yet that this new virus strain will have any increased risk to human health," the news agency reports.

7 Sep 2011

NanoViricides selects NV-INF-1 anti-influenza drug for FDA submission

NanoViricides, Inc. announced today that it has selected a clinical candidate, now designated NV-INF-1, for FDA submission in its highly successful FluCide anti-influenza therapeutics program.

6 Sep 2011

Pharmasset reports SVR results from PSI-7977 phase 2b combination study on HCV genotype 1

Pharmasset, Inc., announced today sustained virologic response (SVR) results from its phase 2b PROTON study with PSI-7977 400 mg dosed once daily in combination with peginterferon alfa 2a and ribavirin (Peg-IFN/RBV) in subjects with hepatitis C virus (HCV) genotype 1 who have not been treated previously. 43 out of 44 (98%) evaluable subjects achieved an SVR12, defined as HCV RNA below the limit of detection (<15 IU/mL) 12 weeks after the completion of treatment.

6 Sep 2011

AMT, NIH enter exclusive license agreement for use of AAV5-based gene therapy vectors

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that it has entered into an exclusive license agreement with the US National Institutes of Health (NIH) for use of adeno-associated virus serotype 5 (AAV5)-based gene therapy vectors for liver and brain indications.

6 Sep 2011

Three cases of novel influenza A virus now linked to agricultural fair in southwestern Pennsylvania

The Pennsylvania departments of Health and Agriculture today announced three cases of a novel influenza A virus have been identified, and are now linked to an agricultural fair in southwestern Pennsylvania.

6 Sep 2011

Circumcision rates decline in the US: Study

A new study has shown that circumcision rates among US baby boys have fallen. According to the Centers for Disease Control and Prevention (CDC), which published the study in the Morbidity and Mortality Weekly Report, circumcision rates dropped from around 62 percent in 1999 to 57 percent in 2008.

5 Sep 2011

Teenagers use medicines frequently without receiving targeted information about risks and benefits

A large proportion of teenagers regularly and frequently take some form of medication without receiving targeted information about the risks and benefits, according to a review of current research, to be presented at the annual congress of the International Pharmaceutical Federation.

5 Sep 2011

Scientists sequence ten variants of E. coli O104:H4 outbreak strain across the world

Ten variants of the deadly Escherichia coli strain that hit Germany in May 2011 have been sequenced across the world. The unprecedented level of collaboration across the scientific community should give insight into how the outbreak arose, says a scientist at the Society for General Microbiology's Autumn Conference 2011.

5 Sep 2011

Researchers discover protein signals responsible for preserving anti-viral antibodies

Our immune system is capable of a remarkable feat: the ability to remember infections for years, even decades, after they have first been encountered and defeated. While the antibodies we make last only about a month, we retain the means of making them for a lifetime.

3 Sep 2011

Roche Diagnostics terminates sales and distribution agreement with Response

Response Biomedical Corporation today announced that Roche Diagnostics has terminated, effective September 30, 2011, the sales and distribution agreement between Roche and Response dated June 25, 2008. Under the terms of that agreement and related agreements, Roche Diagnostics had agreed to distribute Response's cardiovascular point-of-care (POC) tests on the RAMP® 200 Reader in the US.

From Roche Sequencing and Life Science 2 Sep 2011

New IDSA/PIDS guidelines can thwart pneumonia in children

Immunizations, including a yearly flu vaccine, are the best way to protect children from life-threatening pneumonia, according to new guidelines from the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

2 Sep 2011

New clinical data on Bristol-Myers Squibb's NULOJIX to be presented at ESOT 2011 congress

Bristol-Myers Squibb Company today announced that new data on NULOJIX (belatacept) will be presented at the European Society for Organ Transplantation (ESOT) Congress on September 4 -7, 2011 in Glasgow, Scotland, United Kingdom.

2 Sep 2011

HIV/AIDS policies “woefully inadequate” in Britain: Report

AIDS and HIV prevention policies in Britain are “woefully inadequate” and must be improved, a House of Lords committee warned today. The report by the Lord Select Committee is published on the 25th anniversary of the 'Don't Die of Ignorance' campaign, a public health initiative launched to try to stem the spread of the virus.

2 Sep 2011

Engineered virus shows promise in cancer therapy via bloodstream

Scientists have engineered a virus that when injected into the blood, can selectively target cancer cells throughout the body. The virus attacked only tumours, leaving the healthy tissue alone, in a small trial on 23 patients, according to the journal Nature.

2 Sep 2011

Tamiflu resistant flu found in Newcastle, Australia

The influenza pandemic has gathered a lot of action, advice and coverage over the last few years. In 2009, an international H1N1 influenza pandemic led to concerns that there would be a repeat of the 1918 influenza pandemic which resulted in millions of deaths worldwide. The World Health Organization recorded over 37,000 cases of the H1N1 pandemic influenza in Australia and 193 confirmed deaths.

2 Sep 2011

HPV vaccination drives to prevent cervical cancers

Mexico plans to administer the vaccine against human papillomavirus (HPV), which can cause cervical cancer, to all girls beginning next year, the country's health ministry said Tuesday.

31 Aug 2011

Medivir completes enrollment of three TMC435 phase 3 trials on CHC genotype-1 infection

MedivirAB is an emerging researchbased specialty pharmaceutical company focused on infectious diseases. Medivir today announced that its investigational protease inhibitor TMC435, developed by Tibotec Pharmaceuticals, has successfully completed enrollment of three ongoing global phase 3 trials and further reports that all patients are now on TMC435 or active control treatment.

31 Aug 2011

Medivir reports net sales of SEK 444.6 m for 1 January - 30 June 2011

Medivir: Interim period (January 2011 - June 2011). Net sales were SEK 444.6 (35.7) m.

31 Aug 2011

Racial, ethnic and poverty disparities in human papillomavirus vaccination completion

Barriers that hinder young African-American, Hispanic and poor women from completing a series of three vaccinations to prevent human papillomavirus infection (HPV) also leave them at higher risk for cervical cancer and death.

30 Aug 2011

Virus News and Research

Latest Virus News and Research

FDA to review bone drugs; CDC reports parasite may be a risk to blood supply

'No evidence' mutant bird flu virus poses increased risk to humans, WHO and FAO say

NanoViricides selects NV-INF-1 anti-influenza drug for FDA submission

Pharmasset reports SVR results from PSI-7977 phase 2b combination study on HCV genotype 1

AMT, NIH enter exclusive license agreement for use of AAV5-based gene therapy vectors

Three cases of novel influenza A virus now linked to agricultural fair in southwestern Pennsylvania

Circumcision rates decline in the US: Study

Teenagers use medicines frequently without receiving targeted information about risks and benefits

Scientists sequence ten variants of E. coli O104:H4 outbreak strain across the world

Researchers discover protein signals responsible for preserving anti-viral antibodies

Roche Diagnostics terminates sales and distribution agreement with Response

New IDSA/PIDS guidelines can thwart pneumonia in children

New clinical data on Bristol-Myers Squibb's NULOJIX to be presented at ESOT 2011 congress

HIV/AIDS policies “woefully inadequate” in Britain: Report

Engineered virus shows promise in cancer therapy via bloodstream

Tamiflu resistant flu found in Newcastle, Australia

HPV vaccination drives to prevent cervical cancers

Medivir completes enrollment of three TMC435 phase 3 trials on CHC genotype-1 infection

Medivir reports net sales of SEK 444.6 m for 1 January - 30 June 2011

Racial, ethnic and poverty disparities in human papillomavirus vaccination completion

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in